Bio-Techne Corp (TECH) Stock Analysis
Verdict: WATCH (do not buy)
The Merck KGaA buyout at $73 per share caps upside at 2.8%, transforming TECH into a binary arbitrage play with asymmetric downside risk.
Investment score: 48/100
Analysis as of
Is Bio-Techne Corp stock worth reviewing? The TradeMates thesis
Bio-Techne is now an M&A arbitrage play following the $73/share Merck KGaA buyout agreement. The model suggests holding only for the final 2.8% spread if already positioned; new entries at $71 face asymmetric downside risk.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 90/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
Bio-Techne Corp opportunities and risks
What speaks for TECH
- Merger Arbitrage Capture
What speaks against TECH
- Antitrust/Regulatory Blockageageageage
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TECH | 100.0x | 9.2x | 43.4x | 65.0% | 9.0% | 2.4% |
| MTD | 29.6x | 6.2x | 22.1x | 57.8% | 21.4% | 3.1% |
| WST | 46.7x | 7.7x | 29.1x | 36.2% | 16.9% | 1.8% |
| MEDP | 32.5x | 5.6x | 24.2x | 29.1% | 17.2% | 4.9% |
| TEM | n/a | 7.2x | n/a | 69.6% | -22.2% | -2.2% |
| RVTY | 53.8x | 4.3x | 19.5x | 51.4% | 8.3% | 3.9% |
| Peer median | 32.5x | 6.2x | 22.1x | 51.4% | 16.9% | 3.1% |
Frequently asked questions about Bio-Techne Corp (TECH)
Is TECH stock a good investment?
The TradeMates model rates Bio-Techne Corp as WATCH (do not buy) with an investment score of 48/100. Bio-Techne is now an M&A arbitrage play following the $73/share Merck KGaA buyout agreement. The model suggests holding only for the final 2.8% spread if already positioned; new entries at $71 face asymmetric downside risk. This is algorithmic model output, not personal investment advice.
Is TECH stock a buy?
The TradeMates model verdict for TECH is WATCH (do not buy) with an investment score of 48/100. Treat this as a model signal to review, not a personal buy recommendation.